- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Similar Device failure risk due to complications with peripherally inserted central catheter made of different materials: NEJM
In a new trial published in the New England Journal of Medicine it was revealed that hydrophobic or chlorhexidine peripherally inserted central catheters (PICCs) did not reduce the risk of device failure due to infectious or noninfectious complications compared to standard polyurethane PICCs in adults and children. These findings were concluded from a multicentre, randomized controlled superiority trial conducted in three Australian tertiary hospitals by Amanda J. and colleagues.
A multicenter, open-label, randomized trial of 1,098 patients of all ages were referred to the institutions during the study period for placement of PICCs. Patients were then randomized 1:1:1 to one of three PICCs: hydrophobic, chlorhexidine-coated, or standard polyurethane. The primary outcome was the rate of device failure, which was a composite of infectious (such as bloodstream or local infections) and noninfectious (such as thrombosis, catheter breakage, or occlusion) complications. Participants were followed up to 8 weeks after catheter placement.
Key Findings
Device Failure Rates:
Hydrophobic PICCs
Device failure was seen in 21 of 358 participants, which translated to 5.9%.
Chlorhexidine PICCs
Device failure was observed in 36 of 363 participants, equating to 9.9%.
Standard Polyurethane PICCs: Device failure occurred in 22 of 359 participants (6.1%).
Risk differences were small between groups:
Hydrophobic vs. standard polyurethane: −0.2 percentage points (95% CI, −3.7 to 3.2; p=0.89).
Chlorhexidine vs. standard polyurethane: 3.8 percentage points (95% CI, −0.1 to 7.8; p=0.06).
Odds Ratios for Device Failure:
Hydrophobic vs. standard polyurethane: OR 0.96 (95% CI, 0.51 to 1.78).
Chlorhexidine vs. standard polyurethane: OR 1.71 (95% CI, 0.98 to 2.99).
Overall Complications:
Hydrophobic PICCs: Complications occurred in 77 participants (21.5%).
Chlorhexidine PICCs: Complications occurred in 140 participants (38.6%).
Standard Polyurethane PICCs: Complications occurred in 78 participants (21.7%).
Odds ratios for overall complications:
Hydrophobic vs. standard polyurethane: OR 0.99 (95% CI, 0.69 to 1.42).
Chlorhexidine vs. standard polyurethane: OR 2.35 (95% CI, 1.68 to 3.29).
This trial concluded that hydrophobic and chlorhexidine-treated PICCs do not reduce the risk of device failure as compared to standard polyurethane PICCs in patients referred for catheter placement.
Reference:
Dr Riya Dave has completed dentistry from Gujarat University in 2022. She is a dentist and accomplished medical and scientific writer known for her commitment to bridging the gap between clinical expertise and accessible healthcare information. She has been actively involved in writing blogs related to health and wellness.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751